That is necessary, due to the fact that the method a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and be reliable. Simply put, we need to understand how these proteins fold if we want a drug to work. Historically, this has actually been a trial-and-error process (jeff brown genetic sequencer stock). However now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it much simpler to produce drugs that do what they're created to do. This was an advancement almost nobody discovered. However it's going to have extensive ramifications for treating illness. I forecast that Alpha, Fold will be 98% accurate by the end of 2021.
And, naturally, there will be lots of investment opportunities in this space, too. Shifting topics It's going to be a great year for bitcoin. I'm bullish on it in 2021 (brownstone research). That said, I still think bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be surprised if it pulled back perhaps considerably before going higher - jeff brown biotech genome sequencing. I've been covering bitcoin for a long period of time now. Among the very first research study reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial recommendation, I titled my report "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time. We were primarily informing readers. But that's not the big concern anymore. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche business. Mass, Mutual is a relied on 170-year-old organization. So think about that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a huge factor I'm bullish on it this year. white house. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These business raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I anticipate 2021 will be another record year in IPOs. There are so numerous fantastic private companies on the verge of striking the general public markets And I've been working on a brand-new method for you to invest even prior to these business go public.
This chance has actually been building over the last few years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to discover all the details. Go right here to reserve your spot for totally free.
Emma Walsh here, managing editor of the Diary. Regular Journal readers understand that tech isn't our typical beat (diplomatic relations). And when it comes to tech investing, we leave it to the professionals. Fortunately, we have a number of such professionals in our Rolodex. Our coworker Jeff Brown will be familiar to our longtime readers. He is one of the most accomplished tech investing professionals we understand (brownstone research). In reality, he had numerous triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take a look at the huge image and forecast what's simply around the corner.
That consists of things like 5G networks, biotech, synthetic intelligence, and far more. These trends are experiencing rapid growth and developing amazing opportunities for investors. I want to make sure all our readers are prepared for what's next. And with that in mind, let me draw the image of what I see being available in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a subject I have actually been covering for years now. biotech stock. But in spite of what lots of readers might believe, this is a pattern that's simply starting. Even though the COVID-19 pandemic interrupted supply chains last year, an excellent 250 million 5G-enabled devices were still offered.
And all of this eventually caused Apple delaying the release of the 5G-enabled i, Phone 12 by two months (the legacy report predictions). Losing 2 months of production and sales truly impacts how many 5G gadgets are sold in the fiscal year. When you think about all of that, offering 250 million systems is impressive. More significantly, the delays brought on by the pandemic created a lots of suppressed demand. Which need is now going to be pressed into 2021. In reality, I forecast that more than 500 million 5G gadgets will be delivered in 2021 - jeff bezos. Which's not my only 5G forecast When I have actually talked about 5G in the past, I have actually explained its 3 different stages.
In Stage Two, 5G gadgets go on sale. 5G phones and other products begin to reach customers. And in Stage Three, 5G services start to be provided (tech predictions). That's when we begin to see applications working on 5G networks. Consider things like enormous multiplayer video games over a cellphone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will start Phase 3 by this summer season. This starts something of a virtuous cycle: A lot of people don't really appreciate the technology. But they will care if there are interesting applications that can just be accessed with a 5G phone.
That leads to more 5G apps being established. In truth, 5G is going to open up a suite of extraordinary applications: self-driving cars and trucks, the Internet of Things, robotic surgical treatment, and more. All of these technologies require 5G. The investment opportunities going forward will be huge. Stepping away from 5G, the next crucial innovation I anticipate in 2021 is CRISPR genetic editing. CRISPR stands for "clustered frequently interspaced brief palindromic repeat." It's a mouthful. However it's one of the most amazing developments in biotechnology. At a high level, CRISPR is a technology that can edit our hereditary makeup as if it were software.
The program can crash or not operate properly. CRISPR utilizes a similar idea however with our genetic code. "Typos" in our genome can cause illness. CRISPR can fix these "typos." For many years, CRISPR was mostly a niche technology that wasn't well understood. And throughout that time, there were truly only 3 companies operating in this area. However things are altering. CRISPR is no longer simply theoretical. We're seeing actual outcomes. We're treating diseases and seeing that this technology simply works. And as an outcome, a "2nd crop" of early-stage CRISPR companies is going public and providing incredible returns. This entire market is successfully a greenfield opportunity.
There's room for numerous business to exist in this area. last week. And there will be more. That's my forecast for CRISPR in 2021. I anticipate that two or three more genetic editing business will hold their IPOs. Sticking with biotechnology, we are seeing incredible things happening at the merging of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its latest Alpha, Fold software application can accurately predict the folding of a protein based solely on its amino acid sequence with 92. 4% precision. That is essential because the way a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and work.
Historically, this has been an experimental procedure. Today, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're created to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one however several drug treatments produced using this technology. This was among those breakthroughs that practically nobody discovered. However it's going to have extensive implications for treating illness. And, obviously, there will be a lot of financial investment chances in this space, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be surprised if it pulled back maybe considerably before going greater. I've been covering bitcoin for a very long time now. Among the first research reports I ever released was on bitcoin - exponential tech investor. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my recommendation. However at the time of that preliminary recommendation, I titled my report, "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time.
However no one is asking that concern anymore. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche business. jeff brown biotech genome sequencing. Mass, Mutual is a 150-year-old organization. So consider that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge factor why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another perk forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and declares the info depends on date since February 2021, however we might not separately confirm this claim. Given Jeff Brown's past, he likely has a substantial net worth, but we can't hammer down a precise figure at this minute. Brown is best understood for his sage-like ability to pick winning technology stocks. He invested more than 25 years researching technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience offers him an excellent perspective on the marketplace. He's always on the hunt for new opportunities, and he shares numerous of his finest picks in the Near Future Report.
That's high praise, however it's not absurdly reasoned. Brown has an outstanding track record as a stock-picker, and he effectively anticipated a few of the most significant financial events of the past twenty years. Although he doesn't appear to launch his picks to the general public, the service's success is a direct indicator of Brown's stock-picking prowess. Nobody on Wall Street gets it right each time, but Jeff Brown's accurate predictions have actually earned him legions of dedicated followers. That says a lot about his ability. The Near Future Report is published by Brownstone Research study, a popular financial research publisher. Brownstone Research study provides numerous research services with a variety of expertises - tech predictions.
The company is likewise associated with Bonner & Partners, another well-respected research study publisher - tech stock. On its website, Brownstone states its mission is to offer retail investors with professional-grade research study: "For too long, the very best financial investment research has not been available to individual investors. It has actually been usually booked for investment banks, hedge funds, private equity, and high-net-worth clients. future report review. The mission of Brownstone Research study is to make that sort of proprietary research available to any financiers seeking to gain an edge in the marketplaces. The goal is easy to provide special and profitable investment research study discovered no place else." -Brownstone Research site excerpt from the Jeff Brown is the creator of Brownstone Research study, and he likewise serves as the firm's Chief Financial investment Analyst.
With Brown assisting the ship, Brownstone Research study is a powerhouse publisher with lots to offer its clients. After decades of consistent success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a home name throughout most of America. If you know even a bit about the market, you know that he has a credibility as a King Midas of sorts. the legacy report predictions. Everything he touches relies on gold! Jeff is aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big project.
In reality, Brown thinks S.A.V. jeff brown 2020 predictions. could be "the biggest trend of the 2020s, and he's not alone. Have a look at these quotes from other widely known S.A.V. bulls: Elon's next huge act will be marrying 2 cutting-edge technologies: expert system and electrical cars. Musk hopes the mix will help him establish the first fully-autonomous, self-driving cars and trucks ever. It's absolutely nothing brief of the vehicle industry's Holy Grail. As you know, electrical automobiles and self-driving automobile stocks have been big this year, however the Wall Street machine has been huge on buzz without much concrete outcome. Despite an extreme boost in competitors over the previous few years, Brown still believes Musk has the very best opportunity of putting it all together.
tech could be the magic string that connects it all together. S.A.V. means Shared Autonomous Automobile, and it could be the future of transport. Generally, this innovation would enable you to rent your vehicle as an autonomous, self-driving taxi when you're not using it. You simply get out of the car and press a button on an app that tells the cars and truck to "join the fleet." Next thing you know, you're relaxing on your couch while your vehicle shuttles ride-sharers around town. Most importantly, you get to keep a hefty portion of the earnings. It sounds crazy, but it might be closed than you believe.